International consortium publishes the first Primer on Tuberculosis in Nature Reviews Disease Primers
At the start of the 47th Union World Conference on Lung Health in Liverpool, UK, an international group of top TB experts from several leading institutions published a primer on tuberculosis (TB) in the journal Nature Reviews Disease Primers (http://www.nature.com/nrdp). The 23-page primer, part of a series featuring the latest state-of-the-art advances in various health fields, can be freely downloaded at http://www.nature.com/articles/nrdp201676 for a 1-month period only. Download
Experts from the following institutions contributed to this Primer: McGill International TB Centre, McGill University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; FIND; Aeras; Indian Council of Medical Research; TB Alliance; and the WHO Global TB Programme.
Congratulations to our 2016 Fall Travel Award Winners:
Sophie Huddart (Dr. M. Pai's team). Sophie will be going to the Union North America Region conference.
Nargis Khan (Dr. M. Divangahi's team). Nargis will be going to the Keystone Symposia.
Laura Mendonca (Dr. M. Divangahi's team). Laura will also be going to the Keystone Symposia.
On the eve of the Fifth Replenishment Conference of the Global Fund to Fight AIDS, Tuberculosis and Malaria being hosted in Montreal, McGill University hosted a pre-conference panel to celebrate Canada’s commitment and investment in Global Fund, Stop TB Partnership and other global health initiatives. See here for details
There are many McGill students working to end TB, AIDS, and Malaria. Here are videos featuring our students working to stop TB:
How McGill Student Emily Maclean is helping end TB for Good
How McGill Graduate Robyn S. Lee is helping end TB for Good
How McGill Student Sophie Huddart is helping end TB for Good
How McGill Student Hannah Alsdurf is helping end TB for Good
How McGill Student Laura Mendonca is helping end TB for Good
Post Doctoral Fellowship Positions in Tuberculosis Research Available:
Recent TB Articles/Publications
Location, location, location: tuberculosis services in highest burden countries. Lancet Global Health
Progression to tuberculosis disease increases with multiple exposures. Eur. Resp. Journal
Tuberculosis. Nature Reviews Disease Primers
Click here for more publications
Putting numbers on the End TB Strategy-an impossible dream? The Lancet Global Health
Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays Microbiology Spectrum
- Click here for entire year's publications
Recent Media Appearances
- We cannot tackle the HIV epidemic without tackling TB
- What you need to know about predatory publishers
- India takes a lead in TB research in a unique mission mode to End TB
- 'Cascade Of Care' Can Help India Plug Gaps In TB Treatment
- New Numbers On Tuberculosis Burden Must Galvanize India To Act
- Predatory Conferences Undermine Science And Scam Academics
- What Are Predatory Open Access Journals And Why Should We Worry?
- Canadian medical journals hijacked for junk science
- "Predatory" publisher targets Canada: Offshore firm accused of publishing junk science takes over Canadian journals
- 'Dear Sir Or Madam' Is Not A Smart Way To Apply For Fellowships Or Jobs
- Click here for more
The 100 top-cited tuberculosis research studies
According to a recent study, McGill researchers account for 6% of the world's best cited TB papers which is a very high ranking! The 100 top-cited tuberculosis research studies (International Union Against Tuberculosis and Lung Disease) Download
About the Centre
Our centre brings together over 20 investigators with expertise spanning epidemiology and economic analyses of TB, to microbiology to host genetics and immune response. The work is done both at an academic centre and with a number of collaborating groups around the world. On these pages, we introduce the faculty members who are members of our centre and describe our training programs for students. Find out why our Centre is a world leader in the interdisciplinary study of TB and how we work together to unravel the many mysteries of this recalcitrant disease.